On January 4, 2021, Carlos Garcia-Parada, MBA joined Rocket Pharmaceuticals, Inc. (the ‘Company’) as the Company’s Chief Financial Officer. Mr. Garcia-Parada, age 56, most recently served as the Vice President & Finance Head Oncology USA at Novartis International AG (“Novartis”). Prior to that role, he held positions of increasing seniority at Novartis and its predecessor company Ciba-Geigy AG, beginning in 1988. Mr. Garcia-Parada holds a Master of Business Administration from the University of Chicago – Booth School of Business and a degree in Accounting from Gran Colombia University, Bogota, Colombia.